Certain individuals should be tested for their response to HBV vaccination 1-2 months after the last vaccine dose; these include healthcare workers, sexual partners of those with chronic HBV, patients on chronic hemodialysis, and immunocompromised patients (eg, patients with HIV).
HBV vaccines can be administered as a three-dose series at 0, 1, and 6 months (with or without concurrent hepatitis A vaccine). Alternatively, combination hepatitis A and B vaccine utilizing a four-dose regimen at 0, 7, and 21-30 days and 12 months is available for adults. A two-dose series at 0 and 1 month is another available option for adults.
A double dose of the vaccine series is recommended for immunocompromised individuals (eg, patients with cirrhosis).
Learn more about the prevention of hepatitis B virus.
For additional information, refer to the American Association for the Study of Liver Diseases practice guidelines.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: George Y. Wu. Fast Five Quiz: Hepatitis B Epidemiology and Prevention - Medscape - Mar 03, 2020.